Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Atrioventricular (AV) node conduction velocity refers to the speed at which electrical impulses are transmitted through the AV node, a specialized region of cardiac tissue located in the inferior-posterior region of the interatrial septum. The AV node's primary function is to delay impulse transmission from atria to ventricles, ensuring complete atrial contraction before ventricular contraction. Normal conduction velocity is approximately 0.05 m/sec. Abnormalities can result in arrhythmias like heart block and contribute to reentrant tachycardias.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Atrioventricular Node Conduction Velocity (AV Node Conduction Velocity).